UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (82) 82
life sciences & biomedicine (75) 75
humans (72) 72
female (70) 70
oncology (51) 51
middle aged (28) 28
aged (24) 24
ovarian neoplasms - genetics (24) 24
ovarian neoplasms - pathology (24) 24
ovarian cancer (23) 23
obstetrics & gynecology (22) 22
adult (20) 20
cancer (20) 20
breast neoplasms - drug therapy (16) 16
breast cancer (15) 15
breast neoplasms - pathology (15) 15
treatment outcome (14) 14
aged, 80 and over (13) 13
analysis (13) 13
cell line, tumor (13) 13
disease-free survival (13) 13
gene expression regulation, neoplastic (13) 13
genetic aspects (13) 13
ovarian neoplasms (13) 13
prognosis (13) 13
neoplasm staging (11) 11
research (11) 11
mutation (10) 10
antineoplastic combined chemotherapy protocols - therapeutic use (9) 9
genetic predisposition to disease (9) 9
animals (8) 8
carcinoma (8) 8
endocrine system diseases (8) 8
endometrial cancer (8) 8
endometrial neoplasms - pathology (8) 8
gene expression (8) 8
hematology, oncology and palliative medicine (8) 8
oncology & carcinogenesis (8) 8
ovarian neoplasms - drug therapy (8) 8
risk factors (8) 8
tumors (8) 8
care and treatment (7) 7
chemotherapy (7) 7
dna methylation (7) 7
gene expression profiling (7) 7
health aspects (7) 7
kaplan-meier estimate (7) 7
medicine & public health (7) 7
mice (7) 7
polymorphism, single nucleotide (7) 7
antineoplastic agents - pharmacology (6) 6
antineoplastic agents - therapeutic use (6) 6
antineoplastic combined chemotherapy protocols - pharmacology (6) 6
biomarkers, tumor - genetics (6) 6
breast neoplasms - genetics (6) 6
breast neoplasms - metabolism (6) 6
breast neoplasms - therapy (6) 6
carcinoma, ovarian epithelial (6) 6
clinical trials (6) 6
endometrial neoplasms - drug therapy (6) 6
follow-up studies (6) 6
genes (6) 6
genetics (6) 6
genetics & heredity (6) 6
neoadjuvant therapy (6) 6
neoplasm grading (6) 6
neoplasm invasiveness (6) 6
neoplasms, glandular and epithelial - genetics (6) 6
oncology and carcinogenesis (6) 6
ovarian neoplasms - mortality (6) 6
trastuzumab (6) 6
antibodies, monoclonal - pharmacology (5) 5
antibodies, monoclonal, humanized (5) 5
breast neoplasms - mortality (5) 5
carboplatin - pharmacology (5) 5
chemotherapy, adjuvant (5) 5
cystadenocarcinoma, serous - pathology (5) 5
dose-response relationship, drug (5) 5
drug therapy (5) 5
endometrial neoplasms - genetics (5) 5
epirubicin - administration & dosage (5) 5
female genital diseases and pregnancy complications (5) 5
gene expression regulation, neoplastic - drug effects (5) 5
genome-wide association study (5) 5
immunohistochemistry (5) 5
obstetrics and gynecology (5) 5
remote sensing (5) 5
signal transduction - drug effects (5) 5
survival rate (5) 5
transcriptome (5) 5
tumor cells, cultured (5) 5
up-regulation (5) 5
adjuvant treatment (4) 4
biomarkers (4) 4
brca2 protein - genetics (4) 4
breast neoplasms - chemistry (4) 4
case-control studies (4) 4
cell proliferation (4) 4
cell proliferation - drug effects (4) 4
cohort studies (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2012, ISBN 1849950466, xviii, 230
Book
Journal of clinical oncology, ISSN 1527-7755, 05/2012, Volume 30, Issue 15, pp. 1796 - 1804
Journal Article
by Coleman, Robert L and Oza, Amit M and Lorusso, Domenica and Aghajanian, Carol and Oaknin, Ana and Dean, Andrew and Colombo, Nicoletta and Weberpals, Johanne I and Clamp, Andrew and Scambia, Giovanni and Leary, Alexandra and Holloway, Robert W and Gancedo, Margarita Amenedo and Fong, Peter C and Goh, Jeffrey C and O'Malley, David M and Armstrong, Deborah K and Garcia-Donas, Jesus and Swisher, Elizabeth M and Floquet, Anne and Konecny, Gottfried E and McNeish, Iain A and Scott, Clare L and Cameron, Terri and Maloney, Lara and Isaacson, Jeff and Goble, Sandra and Grace, Caroline and Harding, Thomas C and Raponi, Mitch and Sun, James and Lin, Kevin K and Giordano, Heidi and Ledermann, Jonathan A and Buck, M and Dean, A and Friedlander, M L and Goh, J C and Harnett, P and Kichenadasse, G and Scott, C L and Denys, H and Dirix, L and Vergote, I and Elit, L and Ghatage, P and Oza, A M and Plante, M and Provencher, D and Weberpals, J I and Welch, S and Floquet, A and Gladieff, L and Joly, F and Leary, A and Lortholary, A and Lotz, J and Medioni, J and Tredan, O and You, B and El-Balat, A and Hänle, C and Krabisch, P and Neunhöffer, T and Pölcher, M and Wimberger, P and Amit, A and Kovel, S and Leviov, M and Safra, T and Shapira-Frommer, R and Stemmer, S and Bologna, A and Colombo, N and Lorusso, D and Pignata, S and Sabbatini, R F and Scambia, G and Tamberi, S and Zamagni, C and Fong, P C and O'Donnell, A and Gancedo, M Amenedo and Herraez, A Casado and Garcia-Donas, J and Guerra, E M and Oaknin, A and Palacio, I and Romero, I and Sanchez, A and Banerjee, S N and Clamp, A and Drew, Y and Gabra, H G and Jackson, D and Ledermann, J A and McNeish, I A and Parkinson, C and Powell, M and Aghajanian, C and ... and ARIEL3 investigators and ARIEL3 Investigators
The Lancet (British edition), ISSN 0140-6736, 10/2017, Volume 390, Issue 10106, pp. 1949 - 1961
Rucaparib, a poly(ADP-ribose) polymerase inhibitor, has anticancer activity in recurrent ovarian carcinoma harbouring a BRCA mutation or high percentage of... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Double-Blind Method | Follow-Up Studies | Risk Assessment | Humans | Middle Aged | Ovarian Neoplasms - pathology | Neoplasm Recurrence, Local - drug therapy | Survival Rate | Treatment Outcome | Ovarian Neoplasms - mortality | Neoplasm Recurrence, Local - mortality | Indoles - administration & dosage | Poly(ADP-ribose) Polymerase Inhibitors - administration & dosage | Neoplasm Recurrence, Local - pathology | Disease-Free Survival | Maintenance Chemotherapy - methods | Internationality | Ovarian Neoplasms - therapy | Female | Aged | Molecular Targeted Therapy - methods | Clinical trials | Care and treatment | Carcinoma | Drug therapy | Ovarian cancer | Cancer | Analysis | Chemotherapy | Ovarian carcinoma | Platinum | Biomarkers | Mutation | Cancer therapies | Evidence-based medicine | Tumors | Homologous recombination | Central nervous system | Poly(ADP-ribose) | Homology | Genomes | Fallopian tube | Anticancer properties | Metastases | Homologous recombination repair | Randomization | Pain | Motivation | Ribose | Hemoglobin | Alanine | Anemia | Poly(ADP-ribose) polymerase | Adenosine diphosphate | Breast cancer | Patients | Survival | Heterozygosity | Abdomen | Inhibitors | Point mutation | Loss of heterozygosity | Antitumor activity | Aspartate aminotransferase | Peritoneum | Index Medicus | Abridged Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 01/2017, Volume 18, Issue 1, pp. 75 - 87
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 09/2011, Volume 29, Issue 25, pp. 3351 - 3357
Journal Article
JNCI : Journal of the National Cancer Institute, ISSN 1460-2105, 05/2004, Volume 96, Issue 10, pp. 739 - 749
...ARTICLESRational Combinations of Trastuzumab With Chemotherapeutic Drugs Used in the Treatment of Breast CancerMark D. Pegram, Gottfried E. Konecny, Carminda... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Up-Regulation | Cyclophosphamide - analogs & derivatives | Paclitaxel - pharmacology | Taxoids - pharmacology | Neoplastic Stem Cells - drug effects | Humans | Receptor, ErbB-2 - metabolism | Deoxycytidine - pharmacology | Transplantation, Heterologous | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Breast Neoplasms - metabolism | Antibodies, Monoclonal, Humanized | Vinblastine - analogs & derivatives | Female | Gene Expression Regulation, Neoplastic - drug effects | Receptor, ErbB-2 - drug effects | Disease Models, Animal | Floxuridine - pharmacology | Cell Survival - drug effects | Tumor Stem Cell Assay | Proto-Oncogene Proteins - drug effects | Enzyme-Linked Immunosorbent Assay | Antibodies, Monoclonal - pharmacology | Docetaxel | Breast Neoplasms - drug therapy | DNA, Neoplasm - drug effects | Guanine Nucleotide Exchange Factors | Drug Synergism | Animals | Mice, Nude | Cyclophosphamide - pharmacology | Cell Line, Tumor | Mice | Vinblastine - pharmacology | Carboplatin - pharmacology | Deoxycytidine - analogs & derivatives | Doxorubicin - pharmacology | Trastuzumab | Vinorelbine | Epirubicin - pharmacology | Chemotherapy | Care and treatment | Breast cancer | Research | Health aspects | Drug therapy | Medical treatment | Index Medicus
Journal Article
Journal Article
by Bojesen, Stig E and Pooley, Karen A and Johnatty, Sharon E and Beesley, Jonathan and Michailidou, Kyriaki and Tyrer, Jonathan P and Edwards, Stacey L and Pickett, Hilda A and Shen, Howard C and Smart, Chanel E and Hillman, Kristine M and Mai, Phuong L and Lawrenson, Kate and Stutz, Michael D and Lu, Yi and Karevan, Rod and Woods, Nicholas and Johnston, Rebecca L and French, Juliet D and Chen, Xiaoqing and Weischer, Maren and Nielsen, Sune F and Maranian, Melanie J and Ghoussaini, Maya and Ahmed, Shahana and Baynes, Caroline and Bolla, Manjeet K and Wang, Qin and Dennis, Joe and McGuffog, Lesley and Barrowdale, Daniel and Lee, Anew and Healey, Sue and Lush, Michael and Tessier, Daniel C and Vincent, Daniel and Bacot, Françis and Vergote, Ignace and Lambrechts, Sanina and Despierre, Evelyn and Risch, Harvey A and González-Neira, Anna and Rossing, Mary Anne and Pita, Guillermo and Doherty, Jennifer A and Alvarez, Nuria and Larson, Melissa C and Fridley, Brooke L and Schoof, Nils and Chang-Claude, Jenny and Cicek, Mine S and Peto, Julian and Kalli, Kimberly R and Broeks, Annegien and Armasu, Sebastian M and Schmidt, Marjanka K and Braaf, Linde M and Winterhoff, Boris and Nevanlinna, Heli and Konecny, Gottfried E and Lambrechts, Diether and Rogmann, Lisa and Guénel, Pascal and Teoman, Attila and Milne, Roger L and Garcia, Joaquin J and Cox, Angela and Shridhar, Vijayalakshmi and Burwinkel, Barbara and Marme, Frederik and Hein, Rebecca and Sawyer, Elinor J and Haiman, Christopher A and Wang-Gohrke, Shan and Anulis, Irene L and Moysich, Kirsten B and Hopper, John L and Odunsi, Kunle and Lindblom, Annika and Giles, Graham G and Brenner, Hermann and Simard, Jacques and Lurie, Galina and Fasching, Peter A and Carney, Michael E and Radice, Paolo and Wilkens, Lynne R and Swerdlow, Anthony and Goodman, Marc T and Brauch, Hiltrud and Garcia-Closas, Montserrat and Hillemanns, Peter and Winqvist, Robert and Dürst, Matthias and Devilee, Peter and Runnebaum, Ingo and Jakubowska, Anna and Lubinski, Jan and Mannermaa, Arto and Butzow, Ralf and ... and Gene Environm Interactimi Breast and Kathleen Cuningham Fdn Consortium and Australian Ovarian Canc Study and Epidemiological Study BRCA1 and Hereditary Breast Ovarian Canc Res and Genetic Modifiers Canc Risk BRCA1 and Australian Canc Study and Swedish Breast Canc Study SWE-BRCA and Genetic Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers (GEMO) and Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON) and Gene Environment Interaction and Breast Cancer (GENICA) and Swedish Breast Cancer Study (SWE-BRCA) and Epidemiological study of BRCA1 & BRCA2 Mutation Carriers (EMBRACE) and Australian Ovarian Cancer Study and Australian Cancer Study and Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab) and The Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON)
Nature genetics, ISSN 1061-4036, 2013, Volume 45, Issue 4, pp. 371 - 384
Journal Article